Skip to main content

340B Drug Pricing Program

This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.

Sponsors
Health Resources and Services Administration, Office of Pharmacy Affairs, U.S. Department of Health and Human Services
Deadlines
Oct 15, 2017
Contact
Purpose

The 340B Drug Pricing Program is a federal program that requires drug manufacturers to provide outpatient drugs to eligible healthcare centers, clinics, and hospitals (termed "covered entities") at a reduced price. The program offers a way for eligible safety-net organizations to ensure access to medications.

Comprehensive pharmacy services include patient access to affordable pharmaceuticals, application of "best practices" and efficient pharmacy management and the application of systems that improve patient outcomes through safe and effective medication use. Participation in the Program results in significant savings estimated to be 20% to 50% on the cost of pharmaceuticals for safety-net providers.

Eligibility

All of the following types of entities are eligible to participate in the program by the virtue of their status:

  • Federally Qualified Health Centers and their look-alikes (FQHCs)
  • Family planning projects
  • Entities receiving grants under subpart II of part C of Title XXVI of the Public Health Service Act
  • State-operated AIDS Drug Assistance Programs (ADAPs)
  • Black lung clinics
  • Comprehensive hemophilia diagnostic treatment centers
  • Native Hawaiian health centers
  • Urban Indian organizations
  • Any entity receiving assistance under title XXVI of the Public Health Service Act
  • Entities receiving funds under section 318, if certified by the Secretary
  • Disproportionate share hospitals
  • Children's hospitals
  • Critical Access Hospitals
  • Free-standing cancer hospitals
  • Rural referral centers
  • Sole community hospitals

For a complete and detailed listing of eligibility requirements, see the program website.

Geographic coverage
Nationwide
Amount of funding

The program provides prescription drugs at a reduced cost to eligible entities. Participation in the Program results in significant savings estimated to be 20% to 50% on the cost of pharmaceuticals for safety-net providers.

Application process

A link to the online registration process is available on the program website. Registration must be recertified each year.

Registration periods are open 4 times throughout the year, and are processed in quarterly cycles.

Funding cycles are as follows:

  • October 1 - October 15 for a January 1 start date
  • January 1 - January 15 for an April 1 start date
  • April 1 - April 15 for a July 1 start date
  • July 1 - July 15 for an October 1 start date

Applicants can access a recording of the registration guidelines webinar on the program website.

Tagged as
Critical Access Hospitals · Federally Qualified Health Centers · Healthcare facilities · Medicare · Pharmacy and prescription drugs · Sole Community Hospitals



For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.